Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53BP1 | Q12888 | 4/20 | 0.47 |
| ▸ | F10 | P00742 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24554840 | 0.89 | KMT2A (0.42) | TP53BP1F10ALDH1A1DGAT1NR1H4 | |
| SCHEMBL23366317 | 0.88 | TP53BP1 (0.53) | TP53BP1F10ALDH1A1DGAT1NR1H4 | |
| SCHEMBL22545191 | 0.79 | TP53BP1 (0.52) | TP53BP1F10ALDH1A1DGAT1LMNA | |
| SCHEMBL23366318 | 0.78 | TP53BP1 (0.47) | TP53BP1ALDH1A1DGAT1NR1H4LMNA | |
| SCHEMBL22545083 | 0.77 | KDM4E (0.38) | TP53BP1F10ALDH1A1DGAT1LMNA | |
| SCHEMBL18359680 | 0.74 | SPHK2 (0.49) | F10ALDH1A1NR1H4LMNAKMT2A | |
| SCHEMBL19120376 | 0.72 | KMT2A (0.38) | F10ALDH1A1DGAT1KMT2AGAA | |
| SCHEMBL21972887 | 0.72 | NPC1 (0.61) | TP53BP1ALDH1A1LMNAKMT2AGAA | |
| SCHEMBL24023148 | 0.72 | NR1H4 (0.59) | ALDH1A1NR1H4LMNAKMT2AGAA | |
| SCHEMBL22349844 | 0.71 | TP53BP1 (0.85) | TP53BP1ALDH1A1LMNAKMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11370920-B2 | Fluorescent dyes and their uses as biomarkers | ILLUMINA CAMBRIDGE LIMITED (GB) | 2022-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11370920-B2 | Fluorescent dyes and their uses as biomarkers | FBL, HNRNPF, EWSR1 | TP53BP1 287/4885F10 3188/4885ALDH1A1 895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.